Screening for Fracture Risk in Postmenopausal Women Is Cost-Effective
This showed screening to be cost-effective and to represent an important resource for healthcare decision-making, both in the UK and internationally.
A recent Journal of Bone and Mineral Research analysis indicates that screening for fracture risk in older postmenopausal women is a good use of healthcare resources—in other words, it’s cost-effective.
The analysis examined results from a large randomized controlled trial. Screening, using the FRAX fracture risk calculator in addition to bone density measurements, was highly cost-effective when compared with usual management, with savings due to prevention of all osteoporosis-related fractures and hip fractures.
“This cost-effectiveness study was conducted within a trial of screening to prevent osteoporotic fractures in elderly women. This very large clinical trial, in over 12,000 participants, provided a unique opportunity to investigate the cost-effectiveness of screening using information collected from a single large cohort,” said lead author David Turner, of the University of East Anglia, in the UK. “This showed screening to be cost-effective and to represent an important resource for healthcare decision-making, both in the UK and internationally.”
Additional Information
Link to Study: http://onlinelibrary.wiley.com/doi/10.1002/jbmr.3381/full
About Journal
The JBMR publishes highly competitive original manuscripts, reviews, and special articles in basic and clinical science relevant to bone, muscle and mineral metabolism. Manuscripts are published on the biology and physiology of bone and muscle, relevant systems biology topics (e.g. osteoimmunology), and the pathophysiology and treatment of sarcopenia and disorders of bone and mineral metabolism.
The JBMR publishes highly competitive original manuscripts, reviews, and special articles in basic and clinical science relevant to bone, muscle and mineral metabolism. Manuscripts are published on the biology and physiology of bone and muscle, relevant systems biology topics (e.g. osteoimmunology), and the pathophysiology and treatment of sarcopenia and disorders of bone and mineral metabolism.
( Press Release Image: https://photos.webwire.com/prmedia/6/220725/220725-1.jpg )
WebWireID220725
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.